4.09 USD
▲-0.16+3.54%
盘后 3.96 +0.25%
2026-08-03
市值
$5.10M
市盈率
—
EPS
-45.46
股息率
—
52 周区间
3.68 – 50.40
成交量
8.50K
Beta
1.67
目标价
25.50
52W 低 3.6852W 高 50.40
价格走势
公司简介
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute mye...